Literature DB >> 21808231

The application of permanent middle cerebral artery ligation in the mouse.

Gozde Colak1, Anthony J Filiano, Gail V W Johnson.   

Abstract

Focal cerebral ischemia is among the most common type of stroke seen in patients. Due to the clinical significance there has been a prolonged effort to develop suitable animal models to study the events that unfold during ischemic insult. These techniques include transient or permanent, focal or global ischemia models using many different animal models, with the most common being rodents. The permanent MCA ligation method which is also referred as pMCAo in the literature is used extensively as a focal ischemia model in rodents. This method was originally described for rats by Tamura et al. in 1981. In this protocol a craniotomy was used to access the MCA and the proximal regions were occluded by electrocoagulation. The infarcts involve mostly cortical and sometimes striatal regions depending on the location of the occlusion. This technique is now well established and used in many laboratories. Early use of this technique led to the definition and description of "infarct core" and "penumbra", and it is often used to evaluate potential neuroprotective compounds. Although the initial studies were performed in rats, permanent MCA ligation has been used successfully in mice with slight modifications. This model yields reproducible infarcts and increased post-survival rates. Approximately 80% of the ischemic strokes in humans happen in the MCA area and thus this is a very relevant model for stroke studies. Currently, there is a paucity of effective treatments available to stroke patients, and thus there is a need for good models to test potential pharmacological compounds and evaluate physiological outcomes. This method can also be used for studying intracellular hypoxia response mechanisms in vivo. Here, we present the MCA ligation surgery in a C57/BL6 mouse. We describe the pre-surgical preparation, MCA ligation surgery and 2,3,5 Triphenyltetrazolium chloride (TTC) staining for quantification of infarct volumes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21808231      PMCID: PMC3196186          DOI: 10.3791/3039

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

1.  Progressive derangement of periinfarct viable tissue in ischemic stroke.

Authors:  W D Heiss; M Huber; G R Fink; K Herholz; U Pietrzyk; R Wagner; K Wienhard
Journal:  J Cereb Blood Flow Metab       Date:  1992-03       Impact factor: 6.200

2.  Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion.

Authors:  S P Butcher; R Bullock; D I Graham; J McCulloch
Journal:  Stroke       Date:  1990-12       Impact factor: 7.914

3.  Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model.

Authors:  S A Menzies; J T Hoff; A L Betz
Journal:  Neurosurgery       Date:  1992-07       Impact factor: 4.654

4.  Protective role for type 4 metabotropic glutamate receptors against ischemic brain damage.

Authors:  Slavianka G Moyanova; Federica Mastroiacovo; Lidia V Kortenska; Rumiana G Mitreva; Erminia Fardone; Ines Santolini; Mónica Sobrado; Giuseppe Battaglia; Valeria Bruno; Ferdinando Nicoletti; Richard T Ngomba
Journal:  J Cereb Blood Flow Metab       Date:  2010-12-15       Impact factor: 6.200

5.  Enoxaparin in experimental stroke: neuroprotection and therapeutic window of opportunity.

Authors:  V Mary; F Wahl; A Uzan; J M Stutzmann
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

6.  Focal ischemia of the rat brain: autoradiographic determination of cerebral glucose utilization, glucose content, and blood flow.

Authors:  M Nedergaard; A Gjedde; N H Diemer
Journal:  J Cereb Blood Flow Metab       Date:  1986-08       Impact factor: 6.200

7.  Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion.

Authors:  A Tamura; D I Graham; J McCulloch; G M Teasdale
Journal:  J Cereb Blood Flow Metab       Date:  1981       Impact factor: 6.200

8.  Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

Authors:  J B Bederson; L H Pitts; M Tsuji; M C Nishimura; R L Davis; H Bartkowski
Journal:  Stroke       Date:  1986 May-Jun       Impact factor: 7.914

9.  Temporal evolution of regional energy metabolism following focal cerebral ischemia in the rat.

Authors:  J P Nowicki; C Assumel-Lurdin; D Duverger; E T MacKenzie
Journal:  J Cereb Blood Flow Metab       Date:  1988-08       Impact factor: 6.200

10.  The effects of middle cerebral artery occlusion on central nervous system apoptotic events in normal and diabetic rats.

Authors:  Mark Britton; Jose Rafols; Sarah Alousi; Joseph C Dunbar
Journal:  Int J Exp Diabesity Res       Date:  2003 Jan-Mar
View more
  9 in total

1.  Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.

Authors:  Gozde Colak; Gail V W Johnson
Journal:  Neurobiol Dis       Date:  2011-12-14       Impact factor: 5.996

Review 2.  Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke.

Authors:  Chengli Liu; Jie Xie; Shanshan Sun; Hui Li; Tianyu Li; Chao Jiang; Xuemei Chen; Junmin Wang; Anh Le; Jiarui Wang; Zhanfei Li; Jian Wang; Wei Wang
Journal:  Cell Mol Neurobiol       Date:  2020-10-30       Impact factor: 5.046

3.  Neural Mechanisms of Swallowing Dysfunction and Apraxia of Speech in Acute Stroke.

Authors:  Lydia A Trupe; Rachel W Mulheren; Donna Tippett; Argye E Hillis; Marlís González-Fernández
Journal:  Dysphagia       Date:  2018-02-24       Impact factor: 3.438

4.  Temporal remodeling of pial collaterals and functional deficits in a murine model of ischemic stroke.

Authors:  Benjamin Okyere; Miranda Creasey; Yeonwoo Lebovitz; Michelle H Theus
Journal:  J Neurosci Methods       Date:  2017-09-18       Impact factor: 2.390

5.  The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage.

Authors:  Tatiana Varanita; Maria Eugenia Soriano; Vanina Romanello; Tania Zaglia; Rubén Quintana-Cabrera; Martina Semenzato; Roberta Menabò; Veronica Costa; Gabriele Civiletto; Paola Pesce; Carlo Viscomi; Massimo Zeviani; Fabio Di Lisa; Marco Mongillo; Marco Sandri; Luca Scorrano
Journal:  Cell Metab       Date:  2015-06-02       Impact factor: 27.287

6.  Wnt/β-Catenin Signaling Promotes Differentiation of Ischemia-Activated Adult Neural Stem/Progenitor Cells to Neuronal Precursors.

Authors:  Jan Kriska; Lucie Janeckova; Denisa Kirdajova; Pavel Honsa; Tomas Knotek; David Dzamba; Denisa Kolenicova; Olena Butenko; Martina Vojtechova; Martin Capek; Zbynek Kozmik; Makoto Mark Taketo; Vladimir Korinek; Miroslava Anderova
Journal:  Front Neurosci       Date:  2021-02-25       Impact factor: 4.677

Review 7.  Animal models of stroke.

Authors:  Yanyu Li; Jingjing Zhang
Journal:  Animal Model Exp Med       Date:  2021-09-15

8.  Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models.

Authors:  Beatriz Chamorro; Daniel Diez-Iriepa; Belén Merás-Sáiz; Mourad Chioua; David García-Vieira; Isabel Iriepa; Dimitra Hadjipavlou-Litina; Francisco López-Muñoz; Ricardo Martínez-Murillo; Daniel Gonzàlez-Nieto; Israel Fernández; José Marco-Contelles; María Jesús Oset-Gasque
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

9.  Astrocytic transforming growth factor-beta signaling reduces subacute neuroinflammation after stroke in mice.

Authors:  Egle Cekanaviciute; Nancy Fathali; Kristian P Doyle; Aaron M Williams; Jullet Han; Marion S Buckwalter
Journal:  Glia       Date:  2014-04-15       Impact factor: 7.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.